Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
blinatumomab | b-lymphocyte antigen cd19 | biotech | NA | drugbank , DGIDB | Philadelphia Chromosome[MeSHID:D010677] Relapse[MeSHID:D012008] Burkitt Lymphoma[MeSHID:D002051] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] Diffuse Large B-Cell Lymphoma[MeSHID:D016403] |
3.5 | approved,investigational | activator |
blinatumomab | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Philadelphia Chromosome[MeSHID:D010677] Relapse[MeSHID:D012008] Burkitt Lymphoma[MeSHID:D002051] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] Diffuse Large B-Cell Lymphoma[MeSHID:D016403] |
3.5 | approved | antibody |
blinatumomab | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Philadelphia Chromosome[MeSHID:D010677] Relapse[MeSHID:D012008] Burkitt Lymphoma[MeSHID:D002051] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] Diffuse Large B-Cell Lymphoma[MeSHID:D016403] |
3.5 | approved | unknown |
blinatumomab | b-lymphocyte antigen cd19 | biotech | NA | drugbank , DGIDB | Philadelphia Chromosome[MeSHID:D010677] Relapse[MeSHID:D012008] Burkitt Lymphoma[MeSHID:D002051] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] Diffuse Large B-Cell Lymphoma[MeSHID:D016403] |
3.5 | approved,investigational | activator,antibody |
blinatumomab | t-cell surface glycoprotein cd3 delta chain | biotech | NA | drugbank , DGIDB | Philadelphia Chromosome[MeSHID:D010677] Relapse[MeSHID:D012008] Burkitt Lymphoma[MeSHID:D002051] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] Diffuse Large B-Cell Lymphoma[MeSHID:D016403] |
3.9 | approved,investigational | activator |
click here to return to the previous page |